Dr. Sushama Talegaonkar
Dr. Sushama Talegaonkar
Delhi Pharmaceutical Sciences and Research University, New Delhi
No verified email
Cited by
Cited by
Development and bioavailability assessment of ramipril nanoemulsion formulation
S Shafiq, F Shakeel, S Talegaonkar, FJ Ahmad, RK Khar, M Ali
European journal of pharmaceutics and biopharmaceutics 66 (2), 227-243, 2007
Chitosan–sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: Formulation, optimisation and in vitro characterisation
SK Motwani, S Chopra, S Talegaonkar, K Kohli, FJ Ahmad, RK Khar
European Journal of Pharmaceutics and Biopharmaceutics 68 (3), 513-525, 2008
Nanoemulsion components screening and selection: a technical note
A Azeem, M Rizwan, FJ Ahmad, Z Iqbal, RK Khar, M Aqil, S Talegaonkar
Aaps Pharmscitech 10 (1), 69-76, 2009
Formulation development and optimization using nanoemulsion technique: a technical note
S Shafiq-un-Nabi, F Shakeel, S Talegaonkar, J Ali, S Baboota, A Ahuja, ...
AAPS pharmscitech 8 (2), E12-E17, 2007
Microemulsions: a novel approach to enhanced drug delivery
S Talegaonkar, A Azeem, FJ Ahmad, RK Khar, SA Pathan, ZI Khan
Recent patents on drug delivery & formulation 2 (3), 238-257, 2008
Vesicular systems: an overview
SS Biju, S Talegaonkar, PR Mishra, RK Khar
Indian journal of pharmaceutical sciences 68 (2), 2006
Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy
T Bansal, M Jaggi, R Khar, S Talegaonkar
Journal of pharmacy & pharmaceutical sciences 12 (1), 46-78, 2009
Zinc oxide nanoparticles: a promising nanomaterial for biomedical applications
PK Mishra, H Mishra, A Ekielski, S Talegaonkar, B Vaidya
Drug discovery today 22 (12), 1825-1834, 2017
Intranasal delivery: An approach to bypass the blood brain barrier
S Talegaonkar, PR Mishra
Indian journal of pharmacology 36 (3), 140, 2004
Recent approaches for the treatment of periodontitis
N Jain, GK Jain, S Javed, Z Iqbal, S Talegaonkar, FJ Ahmad, RK Khar
Drug discovery today 13 (21-22), 932-943, 2008
Metal nanoparticles: a theranostic nanotool against cancer
H Sharma, PK Mishra, S Talegaonkar, B Vaidya
Drug discovery today 20 (9), 1143-1151, 2015
CNS drug delivery systems: novel approaches
SA Pathan, Z Iqbal, S Zaidi, S Talegaonkar, D Vohra, GK Jain, A Azeem, ...
Recent patents on drug delivery & formulation 3 (1), 71-89, 2009
Novel formulation approaches for optimising delivery of anticancer drugs based on P-glycoprotein modulation
T Bansal, N Akhtar, M Jaggi, RK Khar, S Talegaonkar
Drug discovery today 14 (21-22), 1067-1074, 2009
Microemulsions as a surrogate carrier for dermal drug delivery
A Azeem, ZI Khan, M Aqil, FJ Ahmad, RK Khar, S Talegaonkar
Drug development and industrial pharmacy 35 (5), 525-547, 2009
Effect of P-glycoprotein inhibitor, verapamil, on oral bioavailability and pharmacokinetics of irinotecan in rats
T Bansal, G Mishra, M Jaggi, RK Khar, S Talegaonkar
european journal of pharmaceutical sciences 36 (4-5), 580-590, 2009
Multiple emulsions: an overview
A Yaqoob Khan, S Talegaonkar, Z Iqbal, F Jalees Ahmed, R Krishan Khar
Current drug delivery 3 (4), 429-443, 2006
Advances and potential applications of chitosan derivatives as mucoadhesive biomaterials in modern drug delivery
S Chopra, S Mahdi, J Kaur, Z Iqbal, S Talegaonkar, FJ Ahmad
Journal of Pharmacy and Pharmacology 58 (8), 1021-1032, 2006
Design and development of oral oil in water ramipril nanoemulsion formulation: in vitro and in vivo assessment
S Shafiq, F Shakeel, S Talegaonkar, FJ Ahmad, RK Khar, M Ali
Journal of Biomedical Nanotechnology 3 (1), 28-44, 2007
The emerging role of P-glycoprotein inhibitors in drug delivery: a patent review
N Akhtar, A Ahad, RK Khar, M Jaggi, M Aqil, Z Iqbal, FJ Ahmad, ...
Expert opinion on therapeutic patents 21 (4), 561-576, 2011
Role of CD44 in tumour progression and strategies for targeting
LM Negi, S Talegaonkar, M Jaggi, FJ Ahmad, Z Iqbal, RK Khar
Journal of drug targeting 20 (7), 561-573, 2012
The system can't perform the operation now. Try again later.
Articles 1–20